// App-Quantinova.ai

5437 : A novel method to quantify gamma H2AX foci in circulating tumor cells in patients receiving chemotherapy for colorectal cancer

Researchers

Presenter

  • Matilde Saggese

Principal Investigators

  • Leah Ensell

  • Clare Vesely

  • Victoria Spanswick

  • Elena Peruzzi

  • Diana Cunati

  • Giulio Signorini

  • John Hartley

  • Hendrik Tobias Arkenau

  • Tim Meyer

Medical Centers

  • UCL/SCRI-UK, London, United Kingdom

  • Silicon Biosystems Spa, Bologna, Italy

  • NCRI, London, United Kingdom

Locations

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

  • Histone H2AX

Drug/Treatment

  • Fluorescein sodium

  • Oxaliplatin

  • FOLFIRI

  • SN38

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved